PMID- 26602436 OWN - NLM STAT- MEDLINE DCOM- 20170227 LR - 20211203 IS - 1879-1476 (Electronic) IS - 0385-8146 (Linking) VI - 43 IP - 4 DP - 2016 Aug TI - Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma. PG - 433-9 LID - S0385-8146(15)00237-0 [pii] LID - 10.1016/j.anl.2015.10.012 [doi] AB - OBJECTIVE: Previous studies have demonstrated that aberrant Kif2a expression is associated with tumor aggressiveness and poor prognosis in various human cancers. However, the clinicopathological significance of Kif2a in laryngeal squamous cell carcinoma (LSCC) is unknown. The aim of this study is to analyze the prognostic significance of Kif2a, alone and in combination with Ki67 protein expression, in LSCC patients. METHODS: We examined the expression status of Kif2a and Ki67 protein in 165 laryngeal tissues (137 primary tumors and 28 cases of matched normal surgical margins) by immunohistochemistry (IHC) analysis using tissue microarrays. RESULTS: We found that expression correlated with clinical parameters and overall survival (OS). Our results revealed that Kif2a and Ki67 protein expression was significantly higher in cancerous tissues compared to normal surgical margins. High Kif2a protein expression (Kif2a+) was significantly associated with tumor stage (P=0.026) and cervical lymph node metastasis (P=0.034). A significant correlation between Kif2a and Ki67 protein expression was observed (P=0.040). Multivariate analysis revealed that patients with Kif2a+ (hazard ratio [HR] 3.640, 95% confidence interval [CI] 1.253-10.570; P=0.018) and high Ki67 (Ki67+) expression (HR 3.086, 95%CI 1.016-9.371; P=0.047) had poor OS. CONCLUSION: We speculate that Kif2a and Ki67 can be used as prognostic markers for LSCC patients. CI - Copyright (c) 2015 Elsevier Ireland Ltd. All rights reserved. FAU - Zhang, Qicheng AU - Zhang Q AD - Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. FAU - Zhang, Wei AU - Zhang W AD - Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. FAU - Zhang, Jie AU - Zhang J AD - Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. FAU - Xu, Hongli AU - Xu H AD - Department of Otorhinolaryngology Head and Neck Surgery, The Third People's Hospital of Nantong, Nantong, Jiangsu Province, China. FAU - You, Yiwen AU - You Y AD - Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: xuhonglimm@163.com. LA - eng PT - Journal Article DEP - 20151118 PL - Netherlands TA - Auris Nasus Larynx JT - Auris, nasus, larynx JID - 7708170 RN - 0 (KIF2A protein, human) RN - 0 (Ki-67 Antigen) RN - EC 3.6.4.4 (Kinesins) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Carcinoma, Squamous Cell/*metabolism/mortality/pathology MH - Female MH - Head and Neck Neoplasms/*metabolism/mortality/pathology MH - Humans MH - Immunohistochemistry MH - Ki-67 Antigen/*metabolism MH - Kinesins/*metabolism MH - Laryngeal Neoplasms/*metabolism/mortality/pathology MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Neoplasm Staging MH - Prognosis MH - Proportional Hazards Models MH - Squamous Cell Carcinoma of Head and Neck MH - Survival Rate MH - Tissue Array Analysis OTO - NOTNLM OT - Ki67 OT - Kif2a OT - Laryngeal squamous cell carcinoma OT - Prognosis OT - Tissue microarrays EDAT- 2015/11/26 06:00 MHDA- 2017/02/28 06:00 CRDT- 2015/11/26 06:00 PHST- 2015/08/22 00:00 [received] PHST- 2015/10/17 00:00 [revised] PHST- 2015/10/20 00:00 [accepted] PHST- 2015/11/26 06:00 [entrez] PHST- 2015/11/26 06:00 [pubmed] PHST- 2017/02/28 06:00 [medline] AID - S0385-8146(15)00237-0 [pii] AID - 10.1016/j.anl.2015.10.012 [doi] PST - ppublish SO - Auris Nasus Larynx. 2016 Aug;43(4):433-9. doi: 10.1016/j.anl.2015.10.012. Epub 2015 Nov 18.